University of California San Francisco
Give to UCSFAfter diagnosing a middle-aged man with an incredibly rare and almost always fatal infection, a medical team led by UCSF fellow Natasha Spottiswoode raced to find a treatment that could save his life.
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
UCSF’s Nevan Krogan, PhD, is taking aim at the world’s deadliest diseases by uniting scientists and the biomedical industry to speed treatments.
Quantitative Biosciences Institute’s Nevan Krogan reflects back on the COVID-19 pandemic and how internal and external communications, funding and international partnerships all contributed to a speedy COVID-19 response.
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
While some patients recover from the effects of COVID-19, others experience the aftereffects long after the initial infection. UC San Francisco researchers are studying why some COVID-19 patients
COVID vaccine efficacy varied by age, BMI, sex, and smoking status, with levels changing over six months in a UCSF-led study. Pfizer and Moderna had higher antibody responses than Johnson & Johnson at one month, but Johnson & Johnson overtook them at six months.
Avian flu cases are spiking. Will it spill over into humans?